Company Details
|
|
Address
|
Surrey Technology Centre, 40 Occam Road, Guildford, GU2 7YG
|
|
Telephone
|
01483 685 670
|
|
Fax
|
01483 685 671
|
Executives
|
|
Executive Chairman
|
William Potter (0.20% holding)
|
|
Chief Executive
|
James Barder (1.10% holding)
|
|
Finance Director
|
Derek Martin (0.00% holding)
|
|
Product Devt Director
|
David Davies (0.70% holding)
|
Main Shareholders
|
|
|
Medinvest: 8.3%
Christopher Crabtree: 7.7%
Allianz: 7.4%
W.T. Lamb Investments Ltd: 7.1%
|
Advisers
|
|
Nominated Adviser
|
Canaccord Adams
|
|
Nominated Broker
|
Collins Stewart; Canaccord Adams
|
|
Solicitors
|
Memery Crystal
|
|
Auditors
|
BDO Stoy Hayward
|
|
Registrar
|
Capita Registrars
|
|
Commentary
|
|
Pharmaceutical and medical device group
|
Company Data |
| Code |
FUM |
| Sedol |
GB00332784 |
| Shares In Issue |
57.619 m |
| Indices
|
Aim |
| Entry on AIM |
22/07/2003 |
| Interim Results |
Sep |
| Final Results |
Mar |
| Year End |
Dec |
| Accounts Due |
Apr |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|
